Systemic Racism and Biological Embodiment of Risk in Breast Cancer Mortality

系统性种族主义和乳腺癌死亡率风险的生物学体现

• 批准号: 10709512
• 负责人: Tomi F Akinyemiju
• 金额: $ 78.88万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-23 至 2027-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10709512
• 关键词: Address; Area; Biological; Biological Markers; Black American; Black Populations; Black race; Breast Cancer Model; Breast Cancer Patient; Breast Cancer Risk Factor; Breast Cancer gene; Cancer Etiology; Cancer Prognosis; Cessation of life; Chronic; Clinical; Cohort Studies; Communities; Crows; DNA Methylation; Data; Diagnostic; Disparate; Disparity; Dyslipidemias; Environment; Epigenetic Process; Estrogen receptor negative; Ethnic Population; Evaluation; Exposure to; Fibrinogen; Future; Genes; Genetic; Health; Hyperinsulinism; IL8 gene; Immune; Incidence; Inequity; Inflammation; Inflammatory; Institution; Institutional Racism; Interleukin-10; Interleukin-6; Investigation; Knowledge; Laws; Legal; Life Cycle Stages; Link; Literature; Measures; Mediating; Metabolic; Metabolic Pathway; Modeling; Outcome; Parents; Participant; Pathogenesis; Pathway interactions; Patient Self-Report; Patients; Prevention strategy; Primary Prevention; Process; Prognosis; Prognostic Marker; Prospective Studies; Prospective cohort; Psychosocial Stress; Public Health; Race; Reasons for Geographic And Racial Differences in Stroke; Recording of previous events; Research; Resources; Risk; Risk Factors; Sampling; Socioeconomic Status; Support Groups; Testing; Time; United States; Woman; adverse outcome; allostatic load; biological adaptation to stress; black women; breast cancer survival; cancer health disparity; clinically relevant; cohort; comorbidity; data infrastructure; epigenome; experience; follow-up; hypothalamic-pituitary-adrenal axis; improved; indexing; malignant breast neoplasm; mortality; mortality disparity; mortality risk; multi-ethnic; neoplasm registry; novel; people of color; perceived discrimination; poor health outcome; prognostic model; prospective; pyrosequencing; racial discrimination; racial disparity; racial population; residential segregation; tumor

Black women experience much higher breast cancer mortality than any other race/ethnic group in the US. Despite extensive investigation, the known causes to date do not adequately explain this mortality gap. Largely missing in the disparities literature is a rigorous examination of systemic racism – i.e., how exposure to an overarching environment of systemic racism (SR) might impact breast cancer outcomes in Black women. Multiple lines of evidence, when considered together, indicate this exposure merits investigation. SR (e.g., perceived discrimination, residential segregation) is associated with a range of adverse health effects in Blacks, and chronic psychosocial stress due to SR can become embodied via hyperactivation of the hypothalamic pituitary adrenal (HPA) axis, leading to inflammatory, metabolic and epigenetic dysregulation. Thus, we hypothesize that exposure to SR leads to alterations in key biological pathways, which in turn contribute to excess breast cancer mortality in Black women. No empirical study has directly tested this hypothesis in a single cohort. To address this gap, we will generate a new prospective cohort with 2,498 incident breast cancer and 2,678 sub-cohort random sample from two parent cohorts -- the REasons for Geographic and Racial Differences in Stroke (REGARDS) and Southern Community Cohort Study (SCCS) cohorts. Both parent cohorts over sampled Blacks and include participants from southern states with a history of SR and obtained extensive baseline and biomarker data, enabling us to measure biomarkers of inflammation and metabolic dysregulation. We will newly assess measures of SR at the structural and interpersonal levels and characterize epigenome-wide DNA methylation profiles. Our study will conduct the first thorough prospective evaluation of the distinct influence of SR, above and beyond other racially pattered risk factors, on breast cancer disparities in a large, diverse cohort. By quantifying the distinct impact of SR on breast cancer mortality, and identifying pathways and biomarkers that mediate this association, our study will help improve the poor accuracy of breast cancer prognostic models in Black women, and inform primary prevention strategies focused on mitigating SR to reduce racial disparities in breast cancer mortality

黑人女性患乳腺癌的死亡率比美国其他任何种族/民族都要高得多。 尽管进行了广泛的调查，但迄今已知的原因并不能充分解释这种死亡率差距。大体上 在差异文献中，缺少对系统性种族主义的严格审查--即，如何接触到 系统性种族主义(SR)的总体环境可能会影响黑人女性的乳腺癌预后。 综合考虑，多方面的证据表明，这一暴露值得调查。SR(例如， 感觉到的歧视、居住隔离)与一系列不利的健康影响有关 黑人，以及由SR引起的慢性心理社会压力可以通过过度激活 下丘脑-垂体-肾上腺(HPA)轴，导致炎症、代谢和表观遗传失调。 因此，我们假设暴露在SR中会导致关键生物途径的改变，进而 这是黑人女性乳腺癌死亡率过高的原因之一。没有任何实证研究直接检验这一点。 单一队列中的假设。为了弥补这一差距，我们将产生一个新的预期队列，有2498个 发生乳腺癌和来自两个父母队列的2678个子队列随机样本--原因 卒中的地理和种族差异与南方社区队列研究(SCCS) 一群人。这两个家长都是采样黑人的群体，其中包括来自有历史记录的南部各州的参与者 并获得了广泛的基线和生物标记物数据，使我们能够测量 炎症和代谢失调。我们将在结构和结构上重新评估SR措施 人际水平和表观基因组DNA甲基化图谱的特征。我们的研究将进行第一次 彻底的前瞻性评估SR的独特影响，超越其他种族模式的风险 在一个大的、不同的队列中，影响乳腺癌差异的因素。通过量化SR对以下方面的显著影响 乳腺癌死亡率，并确定调节这种联系的途径和生物标记物，我们的研究将 帮助改善黑人女性乳腺癌预后模型的糟糕准确性，并向初级患者提供信息 预防策略侧重于减轻SR，以减少乳腺癌死亡率的种族差异

项目成果

Association of racial residential segregation with all-cause and cancer-specific mortality in the reasons for geographic and racial differences in stroke (REGARDS) cohort study.

• DOI: 10.1016/j.ssmph.2023.101374
• 发表时间: 2023-06
• 期刊: SSM-POPULATION HEALTH
• 影响因子: 4.7
• 作者: Joshi, Ashwini;Wilson, Lauren E.;Pinheiro, Laura C.;Judd, Suzanne;Akinyemiju, Tomi
• 通讯作者: Akinyemiju, Tomi